Subhashinee S. K. Wijeratne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Subhashinee S. K. Wijeratne has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Janos Zempleni
Bv Department of Nutrition and Health Sciences, University of Nebraska-Lincoln, Lincoln, NE, USA
12 shared publications Susan L. Cuppett
Department of Food Science and Technology, University of Nebraska—Lincoln, Lincoln, Nebraska 68583-0919
4 shared publicationsBaolong Bao
Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE 68583 USA
3 shared publicationsRocio Rodriguez-Melendez
Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE 68583 USA
3 shared publicationsValerie Pestinger
3 shared publicationsLuisa Rios-Avila
2 shared publications
Latest Publications
- Open Access
- 1 May 2013
- Published by Taylor & Francis in Epigenetics
- Vol. 8 (5) , 504-511
Holocarboxylase synthetase synergizes with methyl CpG binding protein 2 and DNA methyltransferase 1 in the transcriptional repression of long-terminal repeats
Holocarboxylase synthetase (HLCS) is a chromatin protein that facilitates the creation of histone H3 lysine 9-methylation (H3K9me) gene repression marks through physical interactions with the histone methyltransferase EHMT-1. HLCS knockdown causes a depletion of H3K9me marks in mammalian cell cultures and severe phenotypes such as short lifespan and low stress resistance in Drosophila melanogaster. HLCS displays a punctuate distribution pattern in chromatin despite lacking a strong DNA-binding domain. Previous studies suggest that the binding of HLCS to chromatin depends on DNA methylation. We tested the hypothesis that HLCS interacts physically with the DNA methyltransferase DNMT1 and the methyl CpG binding protein MeCP2 to facilitate the binding of HLCS to chromatin, and that these interactions contribute toward the repression of long-terminal repeats (LTRs) by H3K9me marks. Co-immunoprecipitation and limited proteolysis assays provided evidence suggesting that HLCS interacts physically with both DNMT1 and MeCP2. The abundance of H3K9me marks was 207% greater in the LTR15 locus in HLCS overexpression human embryonic kidney HEK293 cells compared with controls. This gain in H3K9me was inversely linked with a 87% decrease in mRNA coding for LTRs. Effects of HLCS abundance on LTR expression were abolished when DNA methylation marks were erased by treating cells with 5-azacytidine. We conclude that interactions between DNA methylation and HLCS are crucial for mediating gene repression by H3K9me, thereby providing evidence for epigenetic synergies between the protein biotin ligase HLCS and dietary methyl donors.
- 1 May 2013
- Published by Taylor & Francis in Epigenetics
- Vol. 8 (5) , 504-511
Open AccessHolocarboxylase synthetase synergizes with methyl CpG binding protein 2 and DNA methyltransferase 1 in the transcriptional repression of long-terminal repeats
Holocarboxylase synthetase (HLCS) is a chromatin protein that facilitates the creation of histone H3 lysine 9-methylation (H3K9me) gene repression marks through physical interactions with the histone methyltransferase EHMT-1. HLCS knockdown causes a depletion of H3K9me marks in mammalian cell cultures and severe phenotypes such as short lifespan and low stress resistance in Drosophila melanogaster. HLCS displays a punctuate distribution pattern in chromatin despite lacking a strong DNA-binding domain. Previous studies suggest that the binding of HLCS to chromatin depends on DNA methylation. We tested the hypothesis that HLCS interacts physically with the DNA methyltransferase DNMT1 and the methyl CpG binding protein MeCP2 to facilitate the binding of HLCS to chromatin, and that these interactions contribute toward the repression of long-terminal repeats (LTRs) by H3K9me marks. Co-immunoprecipitation and limited proteolysis assays provided evidence suggesting that HLCS interacts physically with both DNMT1 and MeCP2. The abundance of H3K9me marks was 207% greater in the LTR15 locus in HLCS overexpression human embryonic kidney HEK293 cells compared with controls. This gain in H3K9me was inversely linked with a 87% decrease in mRNA coding for LTRs. Effects of HLCS abundance on LTR expression were abolished when DNA methylation marks were erased by treating cells with 5-azacytidine. We conclude that interactions between DNA methylation and HLCS are crucial for mediating gene repression by H3K9me, thereby providing evidence for epigenetic synergies between the protein biotin ligase HLCS and dietary methyl donors.
- 15 January 2013
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 529 (2) , 105-111
Biotinylation of lysine 16 in histone H4 contributes toward nucleosome condensation
- 15 January 2013
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 529 (2) , 105-111
Biotinylation of lysine 16 in histone H4 contributes toward nucleosome condensation
- 1 December 2011
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 104 (4) , 537-545
Biotinylation is a natural, albeit rare, modification of human histones
- 1 December 2011
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 104 (4) , 537-545
Biotinylation is a natural, albeit rare, modification of human histones
- 1 August 2011
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 412 (1) , 115-120
Human holocarboxylase synthetase with a start site at methionine-58 is the predominant nuclear variant of this protein and has catalytic activity
- 1 August 2011
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 412 (1) , 115-120
Human holocarboxylase synthetase with a start site at methionine-58 is the predominant nuclear variant of this protein and has catalytic activity
- 11 April 2011
- Published by Elsevier in Clinica Chimica Acta
- Vol. 412 (9-10) , 735-739
A 96-well plate assay for high-throughput analysis of holocarboxylase synthetase activity
- 11 April 2011
- Published by Elsevier in Clinica Chimica Acta
- Vol. 412 (9-10) , 735-739
A 96-well plate assay for high-throughput analysis of holocarboxylase synthetase activity
- 1 April 2011
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 22 (4) , 328-333
Novel histone biotinylation marks are enriched in repeat regions and participate in repression of transcriptionally competent genes
- 1 April 2011
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 22 (4) , 328-333
Novel histone biotinylation marks are enriched in repeat regions and participate in repression of transcriptionally competent genes
- Open Access
- 1 September 2010
- Published by Elsevier in The Journal of Nutrition
- Vol. 140 (9) , 1546-1551
Biotin Regulates the Expression of Holocarboxylase Synthetase in the miR-539 Pathway in HEK-293 Cells
Holocarboxylase synthetase (HCS) catalyzes the covalent binding of biotin to carboxylases and histones. In mammals, the expression of HCS depends on
- 1 September 2010
- Published by Elsevier in The Journal of Nutrition
- Vol. 140 (9) , 1546-1551
Open AccessBiotin Regulates the Expression of Holocarboxylase Synthetase in the miR-539 Pathway in HEK-293 Cells
Holocarboxylase synthetase (HCS) catalyzes the covalent binding of biotin to carboxylases and histones. In mammals, the expression of HCS depends on
- 1 April 2010
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 21 (4) , 310-316
K12-biotinylated histone H4 is enriched in telomeric repeats from human lung IMR-90 fibroblasts
- 1 April 2010
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 21 (4) , 310-316
K12-biotinylated histone H4 is enriched in telomeric repeats from human lung IMR-90 fibroblasts
- Open Access
- 1 December 2009
- Published by Elsevier in The Journal of Nutrition
- Vol. 139 (12) , 2389-2392
Repression of Transposable Elements by Histone Biotinylation ,
Transposable elements constitute >40% of the human genome; transposition of these elements increases genome instability and cancer risk. Epigeneti
- 1 December 2009
- Published by Elsevier in The Journal of Nutrition
- Vol. 139 (12) , 2389-2392
Open AccessRepression of Transposable Elements by Histone Biotinylation ,
Transposable elements constitute >40% of the human genome; transposition of these elements increases genome instability and cancer risk. Epigeneti
- Top Cited Papers
- 1 January 2009
- Published by Wiley in BioFactors
- Vol. 35 (1) , 36-46
Biotin
Biotin is a water‐soluble vitamin and serves as a coenzyme for five carboxylases in humans. Biotin is also covalently attached to distinct lysine residues in histones, affecting chromatin structure and mediating gene regulation. This review describes mammalian biotin metabolism, biotin analysis, markers of biotin status, and biological functions of biotin. Proteins such as holocarboxylase synthetase, biotinidase, and the biotin transporters SMVT and MCT1 play crucial roles in biotin homeostasis, and these roles are reviewed here. Possible effects of inadequate biotin intake, drug interactions, and inborn errors of metabolism are discussed, including putative effects on birth defects. © 2009 International Union of Biochemistry and Molecular Biology, Inc.
- 1 January 2009
- Published by Wiley in BioFactors
- Vol. 35 (1) , 36-46
Top Cited PapersBiotin
Biotin is a water‐soluble vitamin and serves as a coenzyme for five carboxylases in humans. Biotin is also covalently attached to distinct lysine residues in histones, affecting chromatin structure and mediating gene regulation. This review describes mammalian biotin metabolism, biotin analysis, markers of biotin status, and biological functions of biotin. Proteins such as holocarboxylase synthetase, biotinidase, and the biotin transporters SMVT and MCT1 play crucial roles in biotin homeostasis, and these roles are reviewed here. Possible effects of inadequate biotin intake, drug interactions, and inborn errors of metabolism are discussed, including putative effects on birth defects. © 2009 International Union of Biochemistry and Molecular Biology, Inc.